Men with melanoma have worse survival rates than women, possibly related to delayed diagnosis, study results published in the Journal of the European Academy of Dermatology and Venereology suggest.
The study was an analysis of data obtained from the Dutch Nationwide Network and Registry of Histopathology and Cytopathology (PALGA). Only data of patients with primary, cutaneous stage 1, 2, and 3 melanoma without clinically detectable nodal disease who were treated in the Netherlands between 2000 and 2014 were included. The Netherlands Cancer Registry was used to obtain follow-up data. Researchers calculated multivariable relative excess risks (RER) to compare relative survival rates in men (n=23,879) and women (n=30,766).